Interview: Rayner CEO, Tim Clover, discusses the year ahead with Cataract Refractive Surgery Today Europe.
Posted on 22/04/2016
“CRST Europe: What can you tell us about RayOne IOLs?
Mr. Clover: We are currently at the point of validation and regulatory approvals, and when we start manufacturing here, in a short time, it will be a wholly new product. It will be leapfrogging, we hope, to the front of the pack in terms of product innovation, and that product will be called RayOne. It will be a fully preloaded lens with a single diameter, able to be inserted through a small incision. It will also feature a few other benefits that I will defer to the launch.”
In a recent interview with Cataract Refractive Surgery Today Europe (CRSTE) – A leading industry publication – Rayner CEO, Tim Clover, discusses Rayner’s transformation, surgeon education and why the company will remain focused on IOLs; the most important piece of the puzzle.
For the complete interview, please click here